Abstract
Background
Workplace exposure to solar ultraviolet (UV) causes malignant melanoma and non-melanoma skin cancer. The evidence for beneficial effects of solar UV exposure in reducing the risks for other cancers is increasing. The intensity of UV radiation at the Earth’s surface is dependent on latitude, but even in northern European countries exposure can be high enough for outdoor work to cause skin cancer.
Growing points
Awareness of the health risks and benefits of occupational solar UV exposure is poor. Actions to reduce the risk of skin cancer have been identified and employers should recognize their responsibility to actively manage these risks. There is evidence for reduced risks for breast, ovarian and colorectal cancer and possibly other cancers linked to solar UV exposure.
Sources of data
This narrative review draws on published scientific articles and material designed to assist identifying strategies to protect workers from solar UV exposure.
Areas of agreement
Solar UV exposure can be harmful. Wavelengths in the UVB range are more effective in causing erythema and DNA damage. Solar UV is the main source of vitamin D for most people. Primary and secondary prevention for skin cancer can potentially eliminate these risks but the evidence for effectiveness is limited.
Areas of controversy
Potential health benefits of UV exposure, particularly for reduced cancer risk. Determining and communicating optimal exposure to maximize health benefits. The risk of non-melanoma skin cancers may be more than doubled for some workers in temperate latitudes.
Areas timely for developing research
Exposure-response epidemiological studies; studies of the health benefits of occupational UV exposure; studies of the effectiveness of intervention strategies to prevent skin cancer. Use of low-cost UV sensors in workplaces.
Keywords: ultraviolet radiation, sunlight, occupational exposure, outdoor work
Background
Ultraviolet (UV) radiation is an invisible part of the electromagnetic spectrum with wavelengths shorter than those of visible light. The main source of UV exposure is sunlight, although some industrial processes, such as electric arc welding, may also emit anthropogenic UV radiation. We conventionally divide the UV spectrum into three bands based on the interaction of the radiation with matter and human cells: UVC (100–280 nm wavelength) is completely absorbed in the Earth’s stratosphere by ozone and so is very rarely a hazard to health (other than through accidental exposure from artificial UV sources1); UVB (280–315 nm) is also absorbed in the atmosphere, but around 5% penetrates to ground level and damages the upper level of the epidermis due to its short wavelength; and UVA (315–400 nm) is poorly absorbed in the atmosphere and penetrates more deeply into skin, reaching collagen fibres and this is why UVA exposure causes skin ageing.2 The ratio of UVA to UVB in incoming solar irradiance is around 20:1, although this varies with latitude, season, time of the day and atmospheric conditions such as cloud cover, given that these attenuate UVB more than UVA.3
For most people UV radiation is the main source of vitamin D, although diet and supplements also contribute to circulating vitamin D (25-hydroxyvitamin D or 25(OH)D).4 Vitamin D status tends to have a strong seasonal pattern, especially at high latitudes; in winter, around half of the British population will have 25(OH)D levels below 40 nmol/l (1 definition of insufficiency).5 UV, particularly UVB, also has the potential to acutely cause erythema (slight reddening of skin) and then an adaptive increase in epidermal melanin in fair-skinned people. Furthermore, it has the potential to damage DNA, including causing mutations in the p53-gene, resulting in loss of its tumour suppression function and production of reactive oxygen species (ROS) associated with initiation, promotion and progression of skin cancer.6 Dark skin pigmentation is protective against skin damage, including DNA damage.
The International Agency for Research on Cancer (IARC) has classified solar radiation and UVA, UVB and UVC as carcinogenic to humans (Group 1), based on sufficient evidence in human epidemiology and data from experimental animal studies.7 It was concluded that solar radiation causes cutaneous malignant melanoma, along with squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) of the skin (non-melanoma skin cancer, NMSC). IARC also noted positive associations in the epidemiological evidence for exposure to solar radiation and cancer of the lip, conjunctival SSC and ocular melanoma. In addition, IARC classified welding, which can generate UV radiation, as a cause of ocular melanoma. Some rare melanomas, e.g. acral melanoma, are most likely not linked to UV exposure.8
Globally there are 7.7 million cases of NMSC and around 310 000 cases of malignant melanoma annually.9 The incidence and prevalence of both cancer groups have been increasing in many parts of the world over the past 25 years,10 although it is possible that NMSC may be underreported because of removal of lesions without histopathologic assessment.11 Associated Disability Adjusted Life Years lost are highest in ‘High Income’ countries and amongst countries in Central Europe, Eastern Europe and Central Asia. Peters et al.12 estimate that around 6% (4556 cases) of NMSC in Canada were attributable to occupational exposure to solar UV. Rushton et al.13 estimated around 2.3% of NMSC cases in Great Britain (1541 cases, 12 deaths) were attributable to work and, Ruston and Hutchings14 later estimated that 2% of incident cutaneous malignant melanomas (241 cases, 48 deaths) were work-related, although they accept the evidence for a causal association with workplace UV exposure was not entirely convincing. These occupational risks affect outdoor workers, mainly agricultural, construction, public administration and defence, and land transport workers.
The International Commission on Non-Ionizing Radiation Protection (ICNIRP) set a guideline limit for artificial UV exposure on unprotected skin and eyes of 30 J/m2 within an 8-h period.15 Effective irradiance (W/m2) is calculated by weighting spectral irradiance by the ICNIRP action spectrum, for each wavelength interval between 180 and 400 nm. This can be converted to the maximum permissible exposure duration by dividing the ICNIRP guideline (30 J/m2) by the effective irradiance, assuming irradiance is constant.
Exposure is often measured in units of Standard Erythemal Dose (SED; 100 J/m2), to reflect the ability of the radiation to produce erythema 6–24 h after exposure and remain for 24 h thereafter. This is calculated by weighting spectral irradiance by the CIE erythemal action spectrum16 (Fig. 1). The ICNIRP guideline corresponds to between 1.0 and 1.33 SED per day.17 It is recognized that the guideline is conservative and the Minimal Erythemal Dose ranges from 2 SED for someone with fair skin (Fitzpatrick phototype I or II, Celtic) to 15 SED for someone with dark brown or black skin (Fitzpatrick VI); for these phototypes where the skin is adapted for sun exposure the corresponding values are 5 SED (phototype I or II) and 80 SED (phototype VI). Skin pigmentation and its consequences on the effects of UV exposure are discussed by Del Bino et al.18
Fig. 1.

Action spectra for UV exposure (adapted from https://www.temis.nl/uvradiation/product/action.html).
The aim of this narrative review is to outline to non-specialist clinicians the best strategy to balance the detrimental and beneficial cancer risks for workers exposed to solar UV and to discuss controversial areas where the scientific and practice evidence is still emerging. We only focus on cancer, but there are other risks and benefits associated with UV exposure and in practice these also need consideration.19 The paper mostly discusses the issues in relation to European and North American workplaces. No new data were generated or analysed in support of this review.
Workplace exposure to UV radiation and risk management
Exposure measurement
UV irradiance can be accurately measured at fixed locations using radiometers. However, as occupational exposure is dependent on both the local environmental conditions and the behaviour of the workers, personal dosimeters are preferable. There are several devices available, mostly using two general approaches: either photosensitive plastic films that change their optical properties when exposed to UV (chemical UV dosimeters) or semiconductor-based electronic sensors (electronic UV dosimeters).20 The skin’s response to UV depends on the wavelength of the radiation with, for example, the erythemal response between 250 and 400 nm, with the peak response between 250–298 nm (UVB). The biologically relevant UV dose can be estimated by adjusting the measurements using a dimensionless ‘action spectrum’ weighting factor (Fig. 1).
Polysulphone (PSF) film is the commonest material used for chemical UV sensors, usually fabricated into a badge holder that can be worn by the worker.20 The film undergoes degradation on exposure to UV and this increases the absorbance, and the cumulative UV dose can be measured using pre and post measurement of absorbance of the PSF film with a spectrophotometer at 330 nm wavelength. The spectral response of PSF is similar to the erythemal action spectrum. Recently, chemical dosimeters based on photosensitive dyes have been developed (e.g. https://logicink.com/products/daily-suncare-signal), although these are generally only qualitative indicators of exposure.
Electronic dosimeters are generally based around a photodiode sensor with a spectral response designed to match the erythemal action spectrum, with the instantaneous sensor measurements being logged every few seconds. Data can then be downloaded after days or weeks of use and processed by computer. For example, Wittlich and colleagues used electronic dosimeters (the GENESIS-UV system) to undertake measurements of UV exposure for outdoor construction workers from several EU countries (latitude between 34 and 56° N).21 Research suggests that electronic dosimeters and PSF monitors systematically differ in assessment of UV exposure by 20–30%.22 There are also low-cost electronic dosimeters available for consumer use, although they have uncertain accuracy and are generally unsuitable for workplace assessments; all electronic dosimeters require calibration to fixed site ‘research-grade’ measurements to ensure the accuracy of the data.
Measurements of exposure have been undertaken in several northern latitude areas in Europe and North America, including in the UK. Grandahl et al.23 presented data for a range of Danish (latitude 56° N) outdoor workers measured between April and September. Median daily exposure in each month ranged from 1.6 to 2.4 SED, with exposures highest for occupations such as roofers, concrete workers and road workers, and lowest for unskilled labourers, dock workers and carpenters. Data for outdoor workers in Alberta, Canadian (latitude 54° N),24 showed a similar range of exposure depending on job (mean for occupations from 0.7 to 2.6 SED) with an overall daily mean of 1.9 SED. Cherrie et al.25 reported data for British outdoor construction workers with mean exposure of 2.0 SED (latitude 51.5–60° N). Data for Danish masons working outdoors (latitude 56° N) showed mean daily exposures over each month of 0.4–4.7 SED and an overall daily average of 3.2 SED.26 Corresponding data for German workers (latitude 47–55° N) showed slightly higher daily mean exposures over a year of 3.5 SED.
Protective measures
There are no specific legal occupational exposure limits on solar UV exposure in any country around the world.27 Typical official advice to outdoor workers to control risks from solar UV includes (https://www.hse.gov.uk/skin/employ/sunprotect.htm):
Wear long-sleeved top and long trousers;
Wear a hat with a brim or a flap that covers the ears and neck;
If possible, keep in the shade;
Use sunscreen with a high protection factor.
Although these measures can undoubtedly reduce the solar UV exposure of workers using them,17 there is little evidence that they are consistently used. This is probably because they are impractical (unsafe or uncomfortable) or due to workplace culture.28 For example, Peters and colleagues29 questioned 77 outdoor workers in Canada and found that 79% often/always wore hats and 82% wore sleeved shirts, but only 8% consistently sought shade while working and 29% often/always wore sunscreen. In a systematic review of the scientific literature, Reinau and colleagues concluded that the use of sun-protection was essentially inadequate, with many workers reporting they never or rarely wore a long-sleeved shirt (50–80%), sun-protective hats (30–80%) and sunscreen (30–100%).30 Providing shaded areas for breaks and task rotation/flexibility during peak UVR hours may be more effective than relying on personal protective behaviours.31 There is also no good evidence as to the effectiveness of these approaches in preventing skin cancer. For example, Sanchez et al.32 reviewed the evidence from randomized controlled trials for the prevention of NMSC and found only a single uninformative study (because of potential bias). A systematic review and meta-analysis incorporating 29 studies (25 case–control, two cohort, one cross-sectional and one controlled trial, which was included in the review by Sanchez et al.) also found no evidence of protection against skin cancer from sunscreen use.33 Part of the reason for the apparent ineffectiveness of protective strategies for skin cancer may be the attitude of workers towards acquiring a suntan. For example, Miles et al.34 reported results from a survey of UK adults that showed two-thirds of respondents agreed that having a suntan made them look healthier and around half felt that a suntan made them more attractive. Cherrie et al.25 found similar results in their study of outdoor workers in Britain.
Improved information and guidance for workers using electronic media have been suggested as one way of addressing the difficulties in managing UV exposure of outdoor workers. Niu et al.35 carried out a systematic review of digital interventions for sun protection and skin self-examination, such as websites, mobile applications and text messaging. They showed that these interventions were equally or more effective than conventional interventions and more effective than not intervening. However, it is unlikely that this type of approach, on its own, would be sufficient to change long-term behaviour and attitudes of workers to sun exposure.
John and colleagues27 provide a Global Call to Action, launched in 2019 at the 1st Multi-Stakeholder Summit on Occupational Skin Cancer, to improve the legislation to protect outdoor workers from solar UV and to provide compensation for workers with NMSC, improve and standardize the reporting of NMSC and encourage employers to use tools to measure exposure to UV in the workplace as a perquisite for effective risk management.
Understanding the risk of NMSC in relation to UV exposure and compensation for British workers with these diseases
It is accepted that outdoor workers in the UK, particularly those involved in farming, seafaring, and outdoor construction work, are at increased risk of NMSC, although it is not currently possible for workers in Britain to claim Industrial Injuries Disablement Benefit (IIDB) if they have NMSC caused by their work. The main rationale for this is the absence of consistent evidence relating risk to the duration of outdoor work in the sun from epidemiological studies carried out in the UK.36 Diseases can be prescribed under the IIDB scheme if Government ministers are satisfied that the disease can be caused by work, and it is reasonably certain that such a link can be made in an individual claimant’s circumstances. ‘Reasonably certain’ is taken to mean that it is more likely than not that the disease was caused by the work activities, and this has often been interpreted as the work being linked with a doubling of risk in an epidemiological study.
Recent research from Germany demonstrated clear exposure-response relationships for both SCC37 and BCC38 and exposure to UV from sunlight (Fig. 2 shows the relationships for occupational exposure). These researchers carried out two case–control studies identifying patients with a new cancer diagnosis drawn from eight dermatology clinics throughout Germany along with sex- and age-matched controls without the relevant cancer recruited from regional residents’ registration offices. Information about potential UV exposure throughout life, both at work and from leisure activities, was collected by questionnaire and UV exposure was estimated as SED using an algorithm based on measurements of UV.39 Further analysis of the BCC data showed that the risk was independent of tumour localization, histological subtype and skin colour (n.b. 97% of study participants had Fitzpatrick phototype III or less).40 The researchers found a doubling of the risk for SCC for a lifetime occupational exposure of 6348 SED, with the corresponding figure for BCC being 7945 SED; after adjusting for occupational exposure, non-occupational exposure was not significantly associated with risk for either cancer. In both cases these exposures were around the 90th percentile of occupational exposure for the subjects.
Fig. 2.

The presence of an exposure-response relationship provides an alternative approach to identify jobs where NMSC is more likely than not caused by workplace exposure and workers could therefore be compensated for their disease. If we assume the average exposure of an outdoor worker in Britain was 2 SED, as measured by Cherrie et al.25 amongst outdoor construction workers, on around 140 days each year (using the same assumptions as Schmitt and colleagues37,38 for work between April and October21), then British outdoor workers would on average have a doubled risk of BCC after 28 years and for SCC after 22 years.
There is no definitive list of jobs in Britain which involve outdoor work, although there are such data for jobs in the USA (https://www.onetonline.org) and it is plausible that these would be like British work. This O*NET database contains data obtained by questionnaire on descriptions of the work for use by job seekers and others. Information is available for US Standardized Occupational Codes for ‘Work Context - Outdoors, Exposed to Weather’ and, for example, there are 64 job titles where the workers on average are outside >90% of the time. Around a third of these jobs were in construction and a further third in transportation and installation, maintenance and repair jobs. However, the jobs were distributed through most of the main occupational groups, e.g. postal delivery workers in Office and Administrative Support Occupations, and not all jobs in some groups that might be expected to be at risk were included, e.g. only three of 13 job titles in farming and fishing were identified. Nevertheless, the list could form the basis of identifying jobs at risk of NMSC. In addition, there are Job-Exposure Matrices (JEMs) that have recently been developed to assess UV or visible light exposure in epidemiological studies that could further help identify specific British jobs where workers are at risk of NMSC41–43 and algorithm-based assessments of UV exposure.44
Further research, both on the magnitude of UV exposure and the duration of outdoor work for key occupations in Britain, would be advantageous, although as discussed a practicable way of ascribing jobs where workers are at risk of developing NMSC is available.
Health benefits of UV exposure at work
Summary of the epidemiological evidence
In recent years there has been increasing evidence for possible effects of UV exposure or vitamin D levels, a proxy for UV exposure, on cancers other than skin cancers. Epidemiological studies investigating these risks broadly fall into four categories: effects of supplementation with vitamin D and/or total vitamin D intake, associations with levels of circulating vitamin D pre-diagnosis, associations with estimated exposure to UV and Mendelian randomization (MR) studies. MR studies use single nucleotide polymorphisms (SNPs) at common sites (e.g. the vitamin D binding receptor and vitamin D binding protein) that are associated with lower circulating 25(OH)D concentrations. As these SNPs are presumed to be distributed at random across the population at conception, they act as instrumental variables that are not confounded by factors such as sex, ethnicity or socioeconomic status.
Following from an earlier analysis, Autier and colleagues45 published a systematic review of meta-analyses of vitamin D supplementation and non-skeletal disorders published between 2013 and 2017. They found a small reduction in all-cause mortality associated with daily intake of 10–20 μg (400–800 IU) of vitamin D and a larger and statistically significant reduction in cancer mortality (relative risk 0.88). However, there was no indication of a reduced risk of cancer incidence, and it has been suggested that the mortality results could be due to bias because of the high number of participants who dropped out of the trials before completion.46 More recent reviews and meta-analyses generally support the absence of any benefit of reduced cancer risk from vitamin D supplementation.47
Lopez-Caleya et al.48 carried out a review and meta-analysis of studies that had investigated total vitamin D intake (dietary and supplementation) and incidence of colorectal cancer, which showed a small statistically significant reduction in risk (odds ratio 0.96/100 IU/day of vitamin D, 95% confidence interval (95% CI) 0.93–0.98). MR studies have shown no evidence of any reduction in colorectal cancer risk with increased Vitamin D levels.49 There is no evidence that vitamin D supplementation is associated with a reduced risk of breast cancer.50 However, a meta-analysis of studies of circulating vitamin D and breast cancer showed a protective effect of 25(OH)D and breast cancer development in premenopausal women (odds ratio between the highest and lowest vitamin D categories 0.67, 95% CI 0.49–0.92).51 Hiller et al.52 carried out a systematic review and meta-analysis of epidemiological studies examining exposure to solar UV and breast cancer. They found a lower risk of breast cancer for women spending >1 h per day in the sun during summer over a lifetime or during adulthood compared with less than an hour each day (relative risk 0.84; 95% CI: 0.77–0.91), although there was no association with ambient UV intensity. A large prospective cohort study in the USA investigated incidence of breast cancer in association with UV exposure (expressed as mW/m2), categorized in quintiles.53 In this study, there was no association with the overall incidence of breast cancer, but higher UV levels were associated with a lower risk of estrogen receptor-negative (ER-) breast cancer (hazard ratio 0.73, 95% CI: 0.55–0.99).
Similar reviews and meta-analyses have shown decreased risks for incidence of liver cancer from prospective cohort studies (hazard ratio 0.53, 95% CI: 0.41–0.68 for subjects with the highest serum 25(OH)D compared with those with the lowest concentrations),54head and neck cancer incidence from studies assessing vitamin D intake from diet, gene polymorphisms and circulating 25(OH)D,55lung cancer (odds ratio 0.90, 95% CI: 0.83–0.97)56 and ovarian cancer from recent Mendelian randomization studies.57 A recent MR study that used 74 SNPs (~4% of the phenotypic variation in 25(OH)D)) found that only 2 out of 10 cancers studied had an association with vitamin D—ovarian cancer (OR 0.89 (95%CI 0.82–0.96) and BCC (OR 1.16 (95%CI 1.04–1.28) per 1 SD change).58 Although earlier studies of prostate cancer had suggested a protective effect of vitamin D, more recent evidence suggests this is not the case.59
Overall, the epidemiological data are supportive of reduced risks for breast, ovarian and colorectal cancer and possibly other cancers linked to solar UV exposure, although the evidence is weaker for that association being mediated by vitamin D status, particularly intake via supplementation. Several causal mechanisms mediated by vitamin D have been postulated, including reduction in cell proliferation, suppression of systemic inflammation and inhibition of angiogenesis.60 However, given that supplementation with vitamin D has not shown any reduction in cancer risk, it is possible that the causal pathway involves other non-vitamin D pathways, e.g. epidermal nitric oxide production from UVA.61 In any case, it seems likely that there is some trade-off between the risk of skin cancer from UV exposure and the benefit from reduced risk of other cancers.
Balancing the potential benefits with the harms
Designing control measures for UV exposure of outdoor workers is complex because of the necessity to ensure that individuals understand that some exposure is necessary for good health but too much exposure can be harmful. It is prudent to seek UV exposure to ensure vitamin D sufficiency throughout the winter, but the necessary duration of exposure will vary depending on the latitude, local weather, the pattern of work, clothing worn, individual skin colour and oral vitamin D intake. For fair-skinned people in Britain it has been estimated that around 10-min exposure daily at midday would be sufficient to ensure almost all people had adequate circulating 25(OH)D throughout winter (>25 nmol/l), provided about 35% of their skin was exposed (face, hands, forearms and lower legs).62 The corresponding time for people with brown skin (Fitzpatrick skin type V) is about 25 min daily.63 Both these estimates are based on cautiously limiting UV exposure to minimize any skin cancer risk and consequently the researchers suggest that only exposing the hands and face is inadequate. However, if there are important health benefits from UV exposure, then greater exposure could be acceptable to enable workers with a smaller area of skin exposed (e.g. hands and face comprising 10% of skin area) to maintain sufficient vitamin D throughout the year.
Discussion
New information on the exposure-response relationships between solar UV exposure and NMSC have been recently published.37,38 These have relied on systematic measurements of UV made with relatively low-cost instrumentation. There is an urgent need for these studies to be replicated in other contexts to substantiate the conclusions. In addition, there are limited research data on the exposure of workers in Britain and most other countries to solar UV, and further efforts to collect such data should be undertaken. Coding these data into a Job-Exposure Matrix or quantitative exposure algorithm would assist the conduct of epidemiological studies.
Clearly, management of occupational solar UV exposure is challenging: excessive exposure may cause skin cancer, whereas insufficient exposure may increase the risk of a range of other cancers and other diseases. To a large extent, the exposure of outdoor workers to solar UV is highly variable and is mediated by personal behaviour rather than just the environment, i.e. the time spent in the sun and the use of personal protective behaviours such as sunscreen and clothing.24 In Britain, the prevailing attitude is that sun exposure and the tan it induces are beneficial, which makes compliance with interventions to control risks low.25 Employers have little understanding of how best to manage sun exposure and there is no specific legislation to mandate actions. It is the responsibility of the employer to manage the environment and the behaviour of workers to ensure that people are working safely.
Ideally, we envisage workplaces taking the lead to ensure that occupational-related UV exposures provide sufficient vitamin D but not cause erythema. However, without better data on these exposures this is difficult to achieve. We suggest that employers should make more use of new low-cost methods to measure solar UV exposure to assess the exposure of their workers and manage the risks; by not relying on workers personal protective practices but changing working schedule and environment, e.g. by providing shaded areas where the work has to be undertaken. In addition, in our view, employers should undertake health surveillance to measure serum vitamin D at the end of Summer (September) to ensure that workers reach around 80.5 nmol/l to maintain 25(OH)D over 25 nmol/l levels through the winter62 (for 97.5% of British workers) and to identify any skin changes suggesting a risk of skin cancer; the latter already being required under health and safety law. Intervention strategies should be based on clearly articulated psychological theories to encourage workers and employers to address UV exposure issues, overcoming barriers from entrenched attitudes to exposure to sunlight, and this could involve greater use of electronic communication via text messages or social media. Strengthening the law to require employers to undertake more appropriate risk management of solar UV could provide important health benefits for workers.
There are many occupations where workers receive very low exposure to solar UV because their work is predominantly indoors, including hospital staff, office and shop workers. There may be scope to reduce the risk of colorectal, ovarian, breast and possibly other cancers for these workers by changing their work to involve some sun exposure during the day. It is likely that this could be achieved by a relatively short exposure (about 30 min daily at lunchtime, from March to September) of the forearms and lower legs.63
Outdoor workers in Britain with NMSC who have long-term exposure to solar UV likely have a risk more than double that of the general population. It would, in our opinion, be practicable to compensate such people under the British IIDB scheme.
Acknowledgements
We are grateful to our colleagues who have provided advice and guidance in writing this review, particularly Dr Miranda Loh.
Mark Cherrie is a Senior Scientist at the IOM in Edinburgh, UK. He is an environmental epidemiologist, interested in how the places where we live and work shape our health across the life course. He has developed population level UV exposure metrics to understand the relationship between UV, vitamin D and several non-skeletal health outcomes.
John Cherrie is an Emeritus Professor of Human Health at Heriot Watt University and a Principal Scientist at the Institute of Occupational Medicine (IOM) in Edinburgh, UK. He is an exposure scientist involved in a wide range of research, including UV exposure of workers. John is a member of the British Workplace Health Expert Committee and the Industrial Injuries Advisory Council.
Contributor Information
J W Cherrie, IOM, Research Avenue North, Edinburgh EH14 4AP, UK; Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, Edinburgh EH14 4AS, UK.
M P C Cherrie, IOM, Research Avenue North, Edinburgh EH14 4AP, UK.
References
- 1. Trevisan A, Piovesan S, Leonardi Aet al. Unusual high exposure to ultraviolet-C radiation. Photochem Photobiol 2006;82:1077–9. [DOI] [PubMed] [Google Scholar]
- 2. WHO . Radiation: Ultraviolet (UV) Radiation. Geneva: WHO, 2016 [Google Scholar]
- 3. Romanhole RC, Ataide JA, Moriel P, Mazzola PG. Update on ultraviolet a and B radiation generated by the sun and artificial lamps and their effects on skin. Int J Cosmet Sci 2015;37:366–70. [DOI] [PubMed] [Google Scholar]
- 4. Spiro A, Buttriss JL. Vitamin D: an overview of vitamin D status and intake in Europe. Nutr Bull 2014;39:322–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860–8. [DOI] [PubMed] [Google Scholar]
- 6. Lee JW, Ratnakumar K, Hung KFet al. Deciphering UV-induced DNA damage responses to prevent and treat skin cancer. Photochem Photobiol 2020;96:478–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ghissassi F, Baan R, Straif Ket al. A review of human carcinogens—part D: radiation. Lancet Oncol 2009;10:751–2. [DOI] [PubMed] [Google Scholar]
- 8. Liu L, Zhang W, Gao T, Li C. Is UV an etiological factor of acral melanoma? J Expo Sci Environ Epidemiol 2016;26:539–45. [DOI] [PubMed] [Google Scholar]
- 9. Collaboration GBODC, Fitzmaurice C, Abate Det al. Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017. JAMA Oncol 2019;5:1749–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Urban K, Mehrmal S, Uppal Pet al. The global burden of skin cancer: a longitudinal analysis from the global burden of disease study, 1990-2017. JAAD Int 2021;2:98–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Anselmo Lima C, Sampaio Lima M, Maria Da Silva Aet al. Do cancer registries play a role in determining the incidence of non-melanoma skin cancers? Eur J Dermatol 2018;28:169–76. [DOI] [PubMed] [Google Scholar]
- 12. Peters CE, Kim J, Song Cet al. Burden of non-melanoma skin cancer attributable to occupational sun exposure in Canada. Int Arch Occup Environ Health 2019;92:1151–7. [DOI] [PubMed] [Google Scholar]
- 13. Rushton L, Hutchings SJ, Fortunato Let al. Occupational cancer burden in Great Britain. Br J Cancer 2012;107:S3–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rushton L, Hutchings SJ. The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation. Br J Cancer 2017;116:536–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ICNIRP . Guidelines on limits of exposure to ultraviolet radiiatiion of wavelengths between 180 nm and 400 nm (incoherent optical radiaton). Health Phys 2004;87:171–86. [DOI] [PubMed] [Google Scholar]
- 16. Commission Internationale de l’Eclairage . Standard Erythema Dose, A Review. Technical Report CIE 125-1997. Vienna, Austria: CIE, 1997 [Google Scholar]
- 17. ICNIRP . ICNIRP statement - protection of workers against ultraviolet radiation. Health Phys 2010;99:66–87. [DOI] [PubMed] [Google Scholar]
- 18. Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci 2018;19:2668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Rhee HJ, Vries E, Coebergh JW. Regular sun exposure benefits health. Med Hypotheses 2016;97:34–7. [DOI] [PubMed] [Google Scholar]
- 20. Huang X, Chalmers AN. Review of wearable and portable sensors for monitoring personal solar UV exposure. Ann Biomed Eng 2021;49:964–78. [DOI] [PubMed] [Google Scholar]
- 21. Wittlich M, John SM, Tiplica GSet al. Personal solar ultraviolet radiation dosimetry in an occupational setting across Europe. J Eur Acad Dermatol Venereol 2020;34:1835–41. [DOI] [PubMed] [Google Scholar]
- 22. Strehl C, Heepenstrick T, Knuschke P, Wittlich M. Bringing light into darkness-comparison of different personal dosimeters for assessment of solar ultraviolet exposure. Int J Environ Res Public Health 2021;18:9071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Grandahl K, Eriksen P, Ibler KSet al. Measurements of solar ultraviolet radiation exposure at work and at leisure in Danish workers. Photochem Photobiol 2018;94:807–14. [DOI] [PubMed] [Google Scholar]
- 24. Rydz E, Harper A, Leong Bet al. Solar ultraviolet radiation exposure among outdoor workers in Alberta. Canada Environ Res 2020;189:109902. [DOI] [PubMed] [Google Scholar]
- 25. Cherrie JW, Nioi A, Wendelboe-Nelson Cet al. Exposure to solar UV during outdoor construction work in Britain. Ann Work Expo Health 2021;65:176–82. [DOI] [PubMed] [Google Scholar]
- 26. Moldovan HR, Wittlich M, John SMet al. Exposure to solar UV radiation in outdoor construction workers using personal dosimetry. Environ Res 2020;181:108967. [DOI] [PubMed] [Google Scholar]
- 27. John SM, Garbe C, French LEet al. Improved protection of outdoor workers from solar ultraviolet radiation: position statement. J Eur Acad Dermatol Venereol 2021;35:1278–84. [DOI] [PubMed] [Google Scholar]
- 28. Reeder AI, Gray A, McCool JP. Occupational sun protection: workplace culture, equipment provision and outdoor workers’ characteristics. J Occup Health 2013;55:84–97. [DOI] [PubMed] [Google Scholar]
- 29. Peters CE, Koehoorn MW, Demers PAet al. Outdoor workers’; use of sun protection at work and leisure. Saf Health Work 2016;7:208–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Reinau D, Weiss M, Meier CRet al. Outdoor workers’ sun-related knowledge, attitudes and protective behaviours: a systematic review of cross-sectional and interventional studies. Br J Dermatol 2013;168:928–40. [DOI] [PubMed] [Google Scholar]
- 31. Peters CE, Tenkate T, Heer Eet al. Strategic task and break timing to reduce ultraviolet radiation exposure in outdoor workers. Front Public Health 2020;8:354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Sanchez G, Nova J, Rodriguez-Hernandez AEet al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev 2016;7:CD011161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Silva ESD, Tavares R, Paulitsch FDS, Zhang L. Use of sunscreen and risk of melanoma and non-melanoma skin cancer: a systematic review and meta-analysis. Eur J Dermatol 2018;28:186–201. [DOI] [PubMed] [Google Scholar]
- 34. Miles A, Waller J, Hiom S, Swanston D. SunSmart? Skin cancer knowledge and preventive behaviour in a British population representative sample. Health Educ Res 2005;20:579–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Niu Z, Bhurosy T, Heckman CJ. Digital interventions for promoting sun protection and skin self-examination behaviors: a systematic review. Prev Med Rep 2022;26:101709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. IIAC . Non-Melanoma Skin Cancer and Occupational Exposure to (natural) UV Radiation: IIAC Information Note. London: IIAC, 2018 [Google Scholar]
- 37. Schmitt J, Haufe E, Trautmann Fet al. Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181. Br J Dermatol 2018;178:e161–1. [DOI] [PubMed] [Google Scholar]
- 38. Schmitt J, Haufe E, Trautmann Fet al. Occupational UV-exposure is a major risk factor for basal cell carcinoma: results of the population-based case-control study FB-181. J Occup Environ Med 2018;60:36–43. [DOI] [PubMed] [Google Scholar]
- 39. Wittlich M, Westerhausen S, Kleinespel Pet al. An approximation of occupational lifetime UVR exposure: algorithm for retrospective assessment and current measurements. J Eur Acad Dermatol Venereol 2016;30:27–33. [DOI] [PubMed] [Google Scholar]
- 40. Bauer A, Haufe E, Heinrich Let al. Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control study. J Occup Med Toxicol 2020;15:28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Boiano JM, Silver SR, Tsai RJet al. Development of job exposure matrices to estimate occupational exposure to solar and artificial ultraviolet radiation. Ann Work Expo Health 2020;64:936–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Vested A, Schlunssen V, Burdorf Aet al. A quantitative general population job exposure matrix for occupational daytime light exposure. Ann Work Expo Health 2019;63:666–78. [DOI] [PubMed] [Google Scholar]
- 43. Würtz E, Cherrie M, Ge Get al. O-312 occupational exposure levels of solar ultraviolet radiation: an EPHOR review. Occup Environ Med 2021;78:A46.2. [Google Scholar]
- 44. Wittlich M. Criteria for occupational health prevention for solar UVR exposed outdoor workers-prevalence, affected parties, and occupational disease. Front Public Health 2022;9:772290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Autier P, Mullie P, Macacu Aet al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 2017;5:986–1004. [DOI] [PubMed] [Google Scholar]
- 46. Bjelakovic G, Gluud LL, Nikolova Det al. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev 2014;6:CD007469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Gnagnarella P, Muzio V, Caini Set al. Vitamin D supplementation and cancer mortality: narrative review of observational studies and clinical trials. Nutrients 2021;13:3285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Lopez-Caleya JF, Ortega-Valin L, Fernandez-Villa Tet al. The role of calcium and vitamin D dietary intake on risk of colorectal cancer: systematic review and meta-analysis of case-control studies. Cancer Causes Control 2021;33:167–82. [DOI] [PubMed] [Google Scholar]
- 49. Cornish AJ, Tomlinson IPM, Houlston RS. Mendelian randomisation: a powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer. Mol Aspects Med 2019;69:41–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Li Z, Wu L, Zhang Jet al. Effect of vitamin D supplementation on risk of breast cancer: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 2021;8:655727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Estebanez N, Gomez-Acebo I, Palazuelos Cet al. Vitamin D exposure and risk of breast cancer: a meta-analysis. Sci Rep 2018;8:9039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Hiller TWR, O'Sullivan DE, Brenner DRet al. Solar ultraviolet radiation and breast cancer risk: a systematic review and meta-analysis. Environ Health Perspect 2020;128:16002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Gregoire AM, VoPham T, Laden Fet al. Residential ultraviolet radiation and breast cancer risk in a large prospective cohort. Environ Int 2021;159:107028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Zhang Y, Jiang X, Li Xet al. Serum vitamin D levels and risk of liver cancer: a systematic review and dose-response meta-analysis of cohort studies. Nutr Cancer 2021;73:1–9. [DOI] [PubMed] [Google Scholar]
- 55. Pu Y, Zhu G, Xu Yet al. Association between vitamin D exposure and head and neck cancer: a systematic review with meta-analysis. Front Immunol 2021;12:627226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Qian M, Lin J, Fu Ret al. The role of vitamin D intake on the prognosis and incidence of lung cancer: a systematic review and meta-analysis. J Nutr Sci Vitaminol (Tokyo) 2021;67:273–82. [DOI] [PubMed] [Google Scholar]
- 57. Guo JZ, Xiao Q, Gao Set al. Review of Mendelian randomization studies on ovarian cancer. Front Oncol 2021;11:681396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Ong JS, Dixon-Suen SC, Han Xet al. A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization. Nat Commun 2021;12:246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Travis RC, Perez-Cornago A, Appleby PNet al. A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk. Cancer Res 2019;79:274–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Puente-Yague M, Cuadrado-Cenzual MA, Ciudad-Cabanas MJet al. Vitamin D: and its role in breast cancer. Kaohsiung J Med Sci 2018;34:423–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Alfredsson L, Armstrong BK, Butterfield DAet al. Insufficient sun exposure has become a real public health problem. Int J Environ Res Public Health 2020;17:5014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Webb A, Kazantzidis A, Kift Ret al. Meeting vitamin D requirements in white Caucasians at UK latitudes: providing a choice. Nutrients 2018;10:497–13. 10.3390/nu10040497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Webb AR, Kazantzidis A, Kift RCet al. Colour counts: sunlight and skin type as drivers of vitamin D deficiency at UK latitudes. Nutrients 2018;10:457. 10.3390/nu10040457. [DOI] [PMC free article] [PubMed] [Google Scholar]
